Voyageur Pharmaceuticals Ltd.
VM.V
TSX
| 05/31/2025 | 02/28/2025 | 11/30/2024 | 08/31/2024 | 05/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -62.45% | -57.66% | -21.15% | 10.18% | 35.99% |
| Total Depreciation and Amortization | -28.57% | -26.67% | -25.00% | -79.69% | -78.79% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 89.76% | 84.97% | 61.28% | 22.56% | -25.90% |
| Change in Net Operating Assets | -130.44% | -107.01% | 738.83% | 748.16% | 158.50% |
| Cash from Operations | -260.59% | -102.72% | 69.44% | 72.34% | 82.01% |
| Capital Expenditure | 9.23% | 2.29% | 6.02% | 13.82% | 18.54% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 9.23% | 2.29% | 6.02% | 9.61% | 14.82% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 234.63% | 216.94% | -58.96% | -58.96% | -79.19% |
| Repurchase of Common Stock | -- | 65.85% | 65.85% | -123.46% | -123.46% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 1,419.72% | 1,867.98% | 317.48% | 133.70% | 76.41% |
| Cash from Financing | 324.43% | 313.56% | -44.52% | -55.66% | -80.29% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 416.69% | 190.42% | 683.65% | 101.76% | 4.15% |